Physician profile
Robert L Sullivan
NPI 1023018041
$733.20
in general payments reported to CMS, 2019-2025
17 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.76 · 2020: $12.17 · 2021: $88.49 · 2022: $55.46 · 2023: $148 · 2024: $108 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $118.21 | 2025 | Xdemvy |
| Coopervision INC. | $103.89 | 2020-2024 | Myday Contact Lens |
| Oyster Point Pharma, INC. | $66.02 | 2022-2024 | Tyrvaya, Ryzumvi |
| Optos, INC. | $55.04 | 2019 | |
| Amgen INC. | $50.66 | 2025 | Tepezza |
| Alcon Vision LLC | $44.37 | 2021-2025 | Simbrinza |
| Horizon Therapeutics Plc | $40.03 | 2023 | Tepezza |
| Biotissue Holdings INC. | $32.71 | 2022-2023 | |
| Allergan, INC. | $32.38 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $28.16 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $26.44 | 2019-2021 | |
| Abbvie INC. | $25.40 | 2024 | |
| Rxsight INC | $24.61 | 2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Bausch & Lomb Americas INC. | $24.55 | 2023 | Vyzulta |
| Dompe US, INC. | $23.36 | 2024 | Oxervate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $20.03 | 2022 | |
| Omeros Corporation | $17.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.